Intellia Therapeutics (NTLA) Earnings Date, Estimates & Call Transcripts → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ntla Stock Alerts $23.72 +0.12 (+0.51%) (As of 05/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 9Before Market OpensConfirmedActual EPS (Feb. 22) -$1.46 Beat By $0.01 Consensus EPS (Feb. 22) -$1.47 Read Call TranscriptListen to Call Get Intellia Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for NTLA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNTLA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NTLA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Intellia Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($1.62)($1.15)($1.45)Q2 20244($1.75)($1.14)($1.50)Q3 20244($1.90)($1.12)($1.58)Q4 20245($2.06)($1.11)($1.49)FY 202416($7.33)($4.52)($6.02)Q1 20251($1.69)($1.69)($1.69)Q2 20251($2.18)($2.18)($2.18)Q3 20252($1.73)($1.62)($1.68)NTLA Earnings Date and InformationIntellia Therapeutics last announced its earnings data on February 22nd, 2024. The reported ($1.46) earnings per share for the quarter, beating the consensus estimate of ($1.47) by $0.01. The firm had revenue of ($1.92) million for the quarter, compared to the consensus estimate of $15.10 million. Intellia Therapeutics has generated ($5.41) earnings per share over the last year (($5.41) diluted earnings per share). Earnings for Intellia Therapeutics are expected to grow in the coming year, from ($5.57) to ($5.51) per share. Intellia Therapeutics has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Intellia Therapeutics will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Intellia Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 2/22/2024Q4 2023($1.47)($1.46)+$0.01($1.46)$15.10 million($1.92) million 11/9/2023Q3 2023($1.52)($1.38)+$0.14($1.38)$12.45 million$11.99 million 8/3/2023Q2 2023($1.32)($1.40)($0.08)($1.40)$12.08 million$13.59 million 5/4/2023Q1 2023($1.41)($1.17)+$0.24($1.17)$11.76 million$12.60 million 2/23/2023Q4 2022($1.40)($1.40)-($1.40)$10.71 million$13.60 million 11/3/2022Q3 2022($1.31)($1.49)($0.18)($1.49)$13.60 million$13.27 million Get the Latest News and Ratings for NTLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($1.31)($1.33)($0.02)($1.33)$9.50 million$14.00 million 5/5/2022Q1 2022($1.11)($1.96)($0.85)($1.96)$8.57 million$11.30 million 2/24/2022Q4 2021($0.91)($1.09)($0.18)($1.09)$7.83 million$12.90 million 11/4/2021Q3 2021($0.85)($0.97)($0.12)($0.97)$8.66 million$7.20 million 8/5/2021Q2 2021($0.61)($1.01)($0.40)($1.01)$12.21 million$6.55 million 5/6/2021Q1 2021($0.66)($0.69)($0.03)($0.69)$8.57 million$6.45 million Intellia Therapeutics Earnings - Frequently Asked Questions When is Intellia Therapeutics's earnings date? Intellia Therapeutics has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on NTLA's earnings history. Did Intellia Therapeutics beat their earnings estimates last quarter? In the previous quarter, Intellia Therapeutics (NASDAQ:NTLA) reported ($1.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.47) by $0.01. Learn more on analysts' earnings estimate vs. NTLA's actual earnings. How can I listen to Intellia Therapeutics's earnings conference call? The conference call for Intellia Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Intellia Therapeutics's conference call transcript? The conference call transcript for Intellia Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Intellia Therapeutics generate each year? Intellia Therapeutics (NASDAQ:NTLA) has a recorded annual revenue of $36.28 million. How much profit does Intellia Therapeutics generate each year? Intellia Therapeutics (NASDAQ:NTLA) has a recorded net income of -$481.19 million. NTLA has generated -$5.41 earnings per share over the last four quarters. What is Intellia Therapeutics's EPS forecast for next year? Intellia Therapeutics's earnings are expected to grow from ($5.57) per share to ($5.51) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CLDX Earnings Results MYGN Earnings Results NEOG Earnings Results QDEL Earnings Results EDIT Earnings Results CLLS Earnings Results SGMO Earnings Results CRSP Earnings Results LNTH Earnings Results KYMR Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:NTLA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press2024 Oil BoomThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceWarren Buffet Stockpiling Gold?Reagan Gold GroupControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
